Monthly Archives: October 2018

SYNOSTE Ltd raises €5.1 million to launch its smart skeletal deformation correction technology

(Helsinki, October 18, 2018) – SYNOSTE Ltd, a Finnish medical device company creates smart solutions for patient-friendly bone-lengthening and bone-deformation correction. The company has raised over five million euros to start clinical investigations and to develop new clinical applications. SYNOSTE’s patented technology platform provides the basis for further disruptive changes in the treatment of congenital, trauma- and

By |2018-10-18T22:54:21+00:00October 18th, 2018|Financial|
Read More

Centric Medical™ Announces 510(k) Clearance of the SATURN™ External Fixation System

October 18, 2018 HUNTLEY, Ill.--(BUSINESS WIRE)--Centric Medical, a division of Life Spine®, Inc., which focuses on developing surgical implants for the treatment of lower distal extremity pathology, announced today That the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the SATURN External Fixation System which consists of rings, struts, threaded rods,

By |2018-10-18T22:35:37+00:00October 18th, 2018|Regulatory|
Read More

The Orthopaedic Implant Company Launches Semi-Extended Tibial Nail Platform

ORLANDO, Fla., Oct. 18, 2018 /PRNewswire/ -- The Orthopaedic Implant Company ("OIC") launched its Semi-Extended Instrumentation for the OIC Tibial Nail from Gaylord Palms Convention Center in Orlando, Florida, at the 2018 Annual Meeting of the Orthopaedic Trauma Association (OTA). "The OIC IM Nail System brings OR efficiency and value to a whole new level," said Itai Nemovicher, President and

By |2018-10-18T20:57:06+00:00October 18th, 2018|Extremities|
Read More

VISEON, Inc. Announces FDA Clearance of the Voyant System for Minimally Invasive Spine Surgery Access, Visualization, and Illumination

October 18, 2018 IRVINE, Calif.--(BUSINESS WIRE)--Viseon, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their Voyant System for Minimally Invasive Spine Surgery, featuring proprietary HD imaging sensor and illumination technology. The Voyant System is composed of a sterile single-use, disposable retractor device with integrated state-of-the-art

By |2018-10-18T18:16:18+00:00October 18th, 2018|Regulatory|
Read More

Kuros Biosciences Advances its Fibrin-PTH (KUR-113) Spinal Fusion Product Candidate Program

SCHLIEREN (ZURICH), Switzerland, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences AG (SIX: KURN) announced today that the Company has reached a key milestone in its Fibrin-PTH (KUR-113) spinal fusion product candidate development program with the submission of a 510(k) regulatory package for its enabling lumbar intervertebral body fusion device to the U.S. Food and Drug

By |2018-10-18T17:16:52+00:00October 18th, 2018|Biologics|
Read More

Simplify Medical Appoints IP Attorney Veteran to VP, General Counsel

SUNNYVALE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Simplify Medical Pty Ltd, maker of the Simplify® cervical artificial disc, today announced that it has appointed Cindy Lynch to Vice President, General Counsel. Ms. Lynch has nearly 15 years of experience providing strategic legal and intellectual property advice to medical device startups. Ms. Lynch’s appointment comes

By |2018-10-18T16:54:00+00:00October 18th, 2018|Spine|
Read More

TransEnterix CEO, Todd Pope Named One of TIME Magazine’s 50 Most Influential People in Health Care 2018

October 18, 2018 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, congratulates its President and Chief Executive Officer, Todd M. Pope, for being named to TIME Magazine's 50 Most Influential People in Health Care for 2018. In this inaugural list,

By |2018-10-18T16:00:55+00:00October 18th, 2018|Robotics, Top Stories|
Read More

Amplitude Surgical – 2017-18 Annual Results: Sales of over €100 Million, up +8% Like-for-Like, and Solid EBITDA Growth of +17%

October 17, 2018 VALENCE, France--(BUSINESS WIRE)--Regulatory News: Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible), a leading French player on the global surgical technology market for lower-limb orthopedics, announces its 2017-18 annual results. Olivier Jallabert, Chairman and CEO of Amplitude Surgical, says: “Our strong growth, with annual sales exceeding €100 million, and the improvement

By |2018-10-18T15:46:43+00:00October 18th, 2018|Financial|
Read More

SI-BONE Announces Pricing of Initial Public Offering

SANTA CLARA, Calif., Oct. 16, 2018 /PRNewswire/ -- SI-BONE, Inc. (Nasdaq: SIBN) ("SI-BONE"), a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System®, today announced the pricing of its initial public offering of 7,200,000 shares of common stock at a price to the public of $15.00 per share. In addition, SI-BONE has granted

By |2018-10-17T21:13:21+00:00October 17th, 2018|Financial|
Read More

Two new studies demonstrate INTERTAN™ Intertrochanteric Antegrade Nail improves patient outcomes and lowers healthcare costs when treating hip fractures

LONDON, Oct. 17, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, today announced at the Orthopaedic Trauma Association Annual Meeting in Orlando, FL USA two new studies showing positive clinical results and cost savings through using its INTERTAN Intertrochanteric Antegrade Nail. Patients recovering from a hip fracture often deal with various complications, including decline in

By |2018-10-17T20:48:34+00:00October 17th, 2018|Recon|
Read More
Odysseus Medical Solutions 2018
RssEmail